Sound Income Strategies LLC Acquires 111,199 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sound Income Strategies LLC grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 85.0% in the 4th quarter, Holdings Channel reports. The fund owned 242,064 shares of the medical instruments supplier’s stock after purchasing an additional 111,199 shares during the quarter. Sound Income Strategies LLC’s holdings in DENTSPLY SIRONA were worth $4,594,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of XRAY. State of Alaska Department of Revenue raised its stake in DENTSPLY SIRONA by 2.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock valued at $637,000 after purchasing an additional 560 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the period. MML Investors Services LLC raised its position in shares of DENTSPLY SIRONA by 2.1% during the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after buying an additional 620 shares during the last quarter. Allworth Financial LP lifted its stake in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 625 shares during the period. Finally, Blue Trust Inc. grew its position in DENTSPLY SIRONA by 15.1% during the third quarter. Blue Trust Inc. now owns 6,492 shares of the medical instruments supplier’s stock worth $162,000 after buying an additional 854 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on XRAY shares. UBS Group cut their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Evercore ISI restated an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Mizuho started coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Ten equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $26.67.

Read Our Latest Analysis on XRAY

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $19.44 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $35.68. The stock has a market capitalization of $3.86 billion, a PE ratio of -9.39, a PEG ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock’s fifty day moving average is $18.98 and its 200-day moving average is $22.74.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter last year, the company posted $0.49 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.29%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.